1. Home
  2. FMN vs RFL Comparison

FMN vs RFL Comparison

Compare FMN & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Federated Hermes Premier Municipal Income Fund

FMN

Federated Hermes Premier Municipal Income Fund

HOLD

Current Price

$11.26

Market Cap

88.0M

Sector

Finance

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$2.24

Market Cap

92.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMN
RFL
Founded
2002
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Real Estate
Sector
Finance
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
88.0M
92.6M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
FMN
RFL
Price
$11.26
$2.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.4K
140.8K
Earning Date
01-01-0001
06-10-2026
Dividend Yield
3.86%
N/A
EPS Growth
N/A
28.28
EPS
N/A
N/A
Revenue
N/A
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.96
52 Week Low
$10.40
$1.12
52 Week High
$11.40
$2.21

Technical Indicators

Market Signals
Indicator
FMN
RFL
Relative Strength Index (RSI) 54.64 82.91
Support Level $10.98 $1.23
Resistance Level $11.33 N/A
Average True Range (ATR) 0.09 0.18
MACD -0.00 0.09
Stochastic Oscillator 55.00 84.67

Price Performance

Historical Comparison
FMN
RFL

About FMN Federated Hermes Premier Municipal Income Fund

Federated Hermes Premier Municipal Income Fund is a United States-based diversified, closed-end management investment company. The investment objective of the fund is to provide current income exempt from federal income tax, including the federal alternative minimum tax by investing in long-term, tax exempt municipal bonds diversified among states, sectors and issuers. Its portfolio of investments comprises different sectors such as hospitals, toll road, senior care, airport, tobacco, and other sectors.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: